Skip to main content
Clinical Trials/NCT01407731
NCT01407731
Completed
Not Applicable

Analysis of Intersectin Expression in Primary Human Neuroblastomas

Children's Oncology Group0 sites20 target enrollmentJuly 2011
ConditionsNeuroblastoma

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Neuroblastoma
Sponsor
Children's Oncology Group
Enrollment
20
Primary Endpoint
ITSN1 is highly expressed in neuroblastoma tumors and plays an important role in the development/progression of these tumors
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

RATIONALE: Studying protein expression in samples of tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help doctors find better ways to treat neuroblastoma.

PURPOSE: This laboratory studying is looking at protein expression in tumor tissue samples from patients with neuroblastoma.

Detailed Description

OBJECTIVES: * To determine whether intersectin (ITSN1) proteins are present at elevated levels in primary human tumor samples. OUTLINE: Archived tumor tissue samples are analyzed for intersectin (ITSN1) expression by western blot assays with enhanced chemiluminescence and exposed to X-ray film. The films are scanned, and levels of ITSN1 signal are quantified by densitometry.

Registry
clinicaltrials.gov
Start Date
July 2011
End Date
May 2016
Last Updated
9 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

ITSN1 is highly expressed in neuroblastoma tumors and plays an important role in the development/progression of these tumors

Similar Trials